Literature DB >> 15925703

Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans.

Bernard Le Foll1, Steven R Goldberg.   

Abstract

Tobacco dependence through cigarette smoking is the leading preventable cause of death in the world and kills nearly 4 million people annually. Nicotine, a psychoactive component of tobacco, is thought to have a major role in tobacco dependence by acting directly as a reinforcer of drug-seeking and drug-taking behavior. However, recent findings obtained with two procedures that are used widely to assess reinforcing effects of drugs in experimental animals, intravenous drug self-administration and conditioned place-preference procedures, demonstrate that environmental factors have a major influence on the reinforcing effects of nicotine. Under some experimental conditions, nicotine is also self-administered reliably by humans. Environmental stimuli that have been associated previously with the self-administration of nicotine can reinstate extinguished drug-seeking behavior in animals and precipitate relapse to smoking behavior in ex-smokers. Innovative medications that target cannabinoid CB(1) and dopamine D(3) receptors and might block specifically the influence of such conditioned environmental stimuli in smokers are in development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925703     DOI: 10.1016/j.tips.2005.04.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  33 in total

1.  Multi-site exploration of sex differences in brain reactivity to smoking cues: Consensus across sites and methodologies.

Authors:  Kelly M Dumais; Teresa R Franklin; Kanchana Jagannathan; Nathan Hager; Michael Gawrysiak; Jennifer Betts; Stacey Farmer; Emily Guthier; Heather Pater; Amy C Janes; Reagan R Wetherill
Journal:  Drug Alcohol Depend       Date:  2017-07-08       Impact factor: 4.492

Review 2.  [Future medications for tobacco and cannabis dependence].

Authors:  Bernard Le Foll; Zuzana Justinova; Gianlugi Tanda; Steven R Goldberg
Journal:  Bull Acad Natl Med       Date:  2008-01       Impact factor: 0.144

3.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

Review 4.  Therapeutic vaccines for chronic diseases: successes and technical challenges.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

Review 5.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

Review 6.  Behavioral mechanisms underlying nicotine reinforcement.

Authors:  Laura E Rupprecht; Tracy T Smith; Rachel L Schassburger; Deanne M Buffalari; Alan F Sved; Eric C Donny
Journal:  Curr Top Behav Neurosci       Date:  2015

7.  Nicotine content and abstinence state have different effects on subjective ratings of positive versus negative reinforcement from smoking.

Authors:  Kimberly P Lindsey; Bethany K Bracken; Robert R Maclean; Elizabeth T Ryan; Scott E Lukas; Blaise Deb Frederick
Journal:  Pharmacol Biochem Behav       Date:  2012-12-03       Impact factor: 3.533

Review 8.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference.

Authors:  Darlene H Brunzell; Yann S Mineur; Rachael L Neve; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2009-02-11       Impact factor: 7.853

10.  Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits.

Authors:  Jennifer A Davis; Thomas J Gould
Journal:  Eur Neuropsychopharmacol       Date:  2009-03-10       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.